Bellicum Pharmaceuticals Inc (BLCM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
Sales | 14 | 660 | 554 | 552 | 0 |
Gross Profit | 14 | 660 | 554 | 552 | N/A |
Operating Expenses | 49,405 | 3,557 | 3,827 | 2,829 | 0 |
Operating Income | -49,391 | -2,897 | -3,273 | -2,277 | N/A |
Interest Expense | 1,753 | 11 | 11 | 16 | 0 |
Other Income | -23,154 | -1,188 | 3 | 3 | 0 |
Pre-tax Income | -74,298 | -4,096 | -3,281 | -2,290 | 0 |
Net Income Continuous | -74,298 | -4,096 | -3,281 | -2,290 | N/A |
Net Income | $-74,298 | $-4,096 | $-3,281 | $-2,290 | $N/A |
EPS Basic Total Ops | -286.30 | -20.80 | -18.10 | -15.20 | N/A |
EPS Basic Continuous Ops | -287.60 | -19.28 | -15.48 | -12.29 | N/A |
EPS Diluted Total Ops | -286.30 | -20.80 | -18.10 | -15.20 | N/A |
EPS Diluted Continuous Ops | -287.60 | -19.28 | -15.48 | -12.29 | N/A |
EBITDA(a) | $-49,209 | $-2,733 | $-3,111 | $-2,118 | $N/A |